trending Market Intelligence /marketintelligence/en/news-insights/trending/_wdjloxwpnvfbl_acum6iq2 content esgSubNav
In This List

Anatara Lifesciences CEO retires; interim named

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Anatara Lifesciences CEO retires; interim named

Anatara Lifesciences Ltd. said Mel Bridges retired as CEO.

Executive director Tracie Ramsdale was named interim CEO.

Jay Hetzel, a nonexecutive director of Anatara, was also appointed interim chairman.

Brisbane, Australia-based Anatara Lifesciences develops nonantibiotic oral solutions for gastrointestinal diseases.